Phase Ib/IIa randomized study of heterologous ChAdOx1-HBV/MVA-HBV therapeutic vaccination (VTP-300) as monotherapy and combined with low-dose nivolumab in virally-suppressed patients with CHB

Won Young Tak, Wan‐Long Chuang, Chi-Yi Chen, Kuo‐Chih Tseng, Young‐Suk Lim, Gin‐Ho Lo, Jeong Heo, Kaushik Agarwal, Louise Bussey, Sui Lynn Teoh, A. Tria, Anthony Brown, Katie Anderson, Antonella Vardeu, Susanne O’Brien, Jakub Kopycinski, Radka Kolenovska, Ellie Barnes, Thomas G. Evans